Skip to main content
Top
Published in: Pediatric Nephrology 11/2011

01-11-2011 | Brief Report

Iron deficiency in children with early chronic kidney disease

Authors: Rossana Baracco, Sermin Saadeh, Rudolph Valentini, Gaurav Kapur, Amrish Jain, Tej K. Mattoo

Published in: Pediatric Nephrology | Issue 11/2011

Login to get access

Abstract

Iron deficiency (ID) contributes to the development of anemia in patients with chronic kidney disease (CKD). The frequency of ID in children with early CKD has not previously been reported. This was a retrospective chart review of children with CKD stages 2 and 3 followed at the CKD clinic of Children’s Hospital of Michigan. ID was defined as low ferritin and transferrin saturation <20%. Patients on iron supplements were considered as iron-deficient cases. There were 50 patients included in the study (72% male) with a mean age of 10.31 (±5.21). The mean glomerular filtration rate (GFR) was 55.4 ml/min/1.73 m2 (±14.61). ID was present in 42% of patients, out of whom almost half (42.9%) presented with anemia. Females had a higher frequency of ID (64.3%). The frequency of ID with anemia increased from 4.3% to 29.6%, (p = 0.03) in stage 2 to stage 3 CKD, respectively. The frequency of ID without anemia also increased with progression of CKD from stage 2 to stage 3, however, the difference was not statistically significant. ID is frequent in patients with early CKD. Monitoring of iron tests and treatment of ID is important in this population of patients.
Literature
1.
go back to reference Staples AO, Wong CS, Smith JM, Gipson DS, Filler G, Warady BA, Martz K, Greenbaum LA (2009) Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol 4:48–56CrossRef Staples AO, Wong CS, Smith JM, Gipson DS, Filler G, Warady BA, Martz K, Greenbaum LA (2009) Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol 4:48–56CrossRef
2.
go back to reference Halterman JS, Kaczorowski JM, Aligne A, Auinger P, Szilagyi P (2001) Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics 107:1381–1386CrossRef Halterman JS, Kaczorowski JM, Aligne A, Auinger P, Szilagyi P (2001) Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics 107:1381–1386CrossRef
3.
go back to reference Lozoff D, Jimenez E, Wolf AW (1991) Long-term developmental outcome of infants with iron deficiency. N Engl J Med 325:687–694CrossRef Lozoff D, Jimenez E, Wolf AW (1991) Long-term developmental outcome of infants with iron deficiency. N Engl J Med 325:687–694CrossRef
4.
go back to reference Fadrowski JJ, Pierce CB, Cole SR, Moxey-Mims M, Warady BA, Furth SL (2008) Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol 3:457–462CrossRef Fadrowski JJ, Pierce CB, Cole SR, Moxey-Mims M, Warady BA, Furth SL (2008) Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol 3:457–462CrossRef
5.
go back to reference Koshy SM, Geary DF (2008) Anemia in children with chronic kidney disease. Pediatr Nephrol 23:209–219CrossRef Koshy SM, Geary DF (2008) Anemia in children with chronic kidney disease. Pediatr Nephrol 23:209–219CrossRef
6.
go back to reference Hudson JQ, Comstock TJ (2001) Considerations for optimal iron use for anemia due to chronic kidney disease. Clin Ther 23:1637–1665CrossRef Hudson JQ, Comstock TJ (2001) Considerations for optimal iron use for anemia due to chronic kidney disease. Clin Ther 23:1637–1665CrossRef
7.
go back to reference KDOQI, National Kidney Foundation (2006) KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47:S11–S145CrossRef KDOQI, National Kidney Foundation (2006) KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47:S11–S145CrossRef
8.
go back to reference Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571–590CrossRef Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571–590CrossRef
9.
go back to reference Wong H, Mylrea K, Feber J, Drukker A, Filler G (2006) Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int 70:585–590CrossRef Wong H, Mylrea K, Feber J, Drukker A, Filler G (2006) Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int 70:585–590CrossRef
10.
go back to reference McGonigle RJ, Boineau FG, Beckman B, Ohene-Frempong K, Lewy JE, Shadduck RK, Fisher JW (1995) Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease. J Lab Clin Med 105:449–458 McGonigle RJ, Boineau FG, Beckman B, Ohene-Frempong K, Lewy JE, Shadduck RK, Fisher JW (1995) Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease. J Lab Clin Med 105:449–458
11.
go back to reference Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S (2002) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110:1037–1044CrossRef Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S (2002) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110:1037–1044CrossRef
12.
go back to reference Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M (2006) Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Am J Hematol 81:832–837CrossRef Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M (2006) Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Am J Hematol 81:832–837CrossRef
13.
go back to reference Pruchnicki MC, Coyle JD, Hoshaw-Woodard S, Bay WH (2002) Effect of phosphate binders on supplemental iron absorption in healthy subjects. J Clin Pharmacol 42:1171–1176CrossRef Pruchnicki MC, Coyle JD, Hoshaw-Woodard S, Bay WH (2002) Effect of phosphate binders on supplemental iron absorption in healthy subjects. J Clin Pharmacol 42:1171–1176CrossRef
14.
go back to reference Fishbane S, Pollack S, Feldman HI, Joffe MM (2009) Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988–2004. Clin J Am Soc Nephrol 4:57–61CrossRef Fishbane S, Pollack S, Feldman HI, Joffe MM (2009) Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988–2004. Clin J Am Soc Nephrol 4:57–61CrossRef
15.
go back to reference Cook JD, Skikne BS (1989) Iron deficiency: definition and diagnosis. J Intern Med 226:349–355CrossRef Cook JD, Skikne BS (1989) Iron deficiency: definition and diagnosis. J Intern Med 226:349–355CrossRef
Metadata
Title
Iron deficiency in children with early chronic kidney disease
Authors
Rossana Baracco
Sermin Saadeh
Rudolph Valentini
Gaurav Kapur
Amrish Jain
Tej K. Mattoo
Publication date
01-11-2011
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 11/2011
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-011-1946-2

Other articles of this Issue 11/2011

Pediatric Nephrology 11/2011 Go to the issue